Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Nina Capital is a specialized venture capital firm founded in 2019 and based in Barcelona, Spain. The firm focuses on investing at the intersection of healthcare and technology, particularly in health technology. Nina Capital emphasizes a methodology known as Biodesign, which prioritizes need-driven and value-based innovations in healthcare. The firm has established itself as a key player in the health tech sector, actively seeking to drive transformation through strategic investments.
Currently, Nina Capital manages a portfolio of 54 companies and operates across multiple geographies, including Europe, the United States, Canada, Israel, and Australia. The firm has a ticket size range from €200,000 to €1,500,000, allowing it to support early-stage companies effectively. Notably, Nina Capital does not invest in drugs and vaccines, focusing instead on technology-driven healthcare solutions.
Nina Capital targets investments in the pre-seed to seed+ stages, concentrating on healthcare transformation through information technology. The firm invests in health technology innovations that are need-driven and value-based, aligning with its Biodesign methodology. This approach emphasizes the importance of addressing unmet clinical needs and enhancing the efficiency of healthcare organizations.
The firm operates primarily in Europe, the United States, Canada, Israel, and Australia, reflecting a broad geographic focus. Nina Capital's check sizes range from €200,000 to €1,500,000, allowing for flexibility in supporting various stages of company development. The firm explicitly avoids investments in drugs and vaccines, concentrating instead on healthcare tools and medical devices that can significantly impact the healthcare landscape.
Nina Capital's portfolio consists of 54 companies, showcasing a diverse range of health technology innovations. Notable portfolio companies include:
This diverse portfolio reflects Nina Capital's commitment to supporting companies that are transforming healthcare through technology.
Marta G. Zanchi - Founder, Managing Partner. Marta has extensive experience in venture capital and healthcare, having led numerous investments in health technology.
Marc Subirats - General Partner. Marc brings a wealth of knowledge in early-stage investments and has a strong background in healthcare innovation.
Jordi Pedrol - Head of Finance. Jordi oversees the financial operations of Nina Capital, ensuring effective fund management.
Sebastian Anastassiou - Partner. Sebastian focuses on identifying promising investment opportunities in the health tech sector.
Yahel Halamish - Partner. Yahel has a strong background in technology and healthcare, contributing to Nina Capital's investment strategy.
Kyle Sherrill - Associate. Kyle supports the investment team in evaluating potential portfolio companies and conducting market research.
To pitch to Nina Capital, interested parties should submit their pitch deck to dealflow@nina.capital. The pitch should include a clear overview of the business model, market opportunity, and team background. Founders are encouraged to provide detailed information about their technology and how it addresses specific healthcare needs. Response times may vary, but founders should expect to hear back within a few weeks.
Nina Capital offers the Nina Fellows program, designed for exceptional interns who have completed their internships. This program allows them to engage with the venture capital world, contributing to activities such as discovering founders and representing Nina Capital at events. Fellows are expected to commit approximately 8-10 hours per month, gaining valuable experience in the venture capital industry.
As of March 2023, Nina Capital has continued to expand its portfolio, now comprising 54 companies. The firm remains active in the health technology sector, focusing on strategic support for its portfolio companies. Recent investments include notable health tech ventures that align with Nina Capital's mission of driving healthcare transformation through technology.
In addition to its investment activities, Nina Capital has been involved in various industry events, representing its portfolio companies and showcasing innovative solutions in healthcare technology.
What are Nina Capital's investment criteria?
Nina Capital invests in early-stage companies at the pre-seed to seed+ stages, focusing on healthcare technology innovations that are need-driven and value-based. The firm emphasizes solutions that enhance healthcare efficiency and address unmet clinical needs.
How can I apply or pitch to Nina Capital?
Interested parties can submit their pitch deck to dealflow@nina.capital. It is advisable to include detailed information about the business model, market opportunity, and team background in the pitch.
What makes Nina Capital different from other venture capital firms?
Nina Capital specializes exclusively in health technology, utilizing the Biodesign methodology to inform its investment decisions. The firm avoids investments in drugs and vaccines, focusing instead on technology-driven solutions that can significantly impact healthcare.
What is the geographic scope of Nina Capital's investments?
Nina Capital operates across multiple geographies, including Europe, the United States, Canada, Israel, and Australia, allowing it to tap into diverse healthcare markets and innovations.
What is Nina Capital's post-investment involvement like?
Nina Capital adds value to its portfolio companies through strategic support in fundraising and market positioning. The firm leverages its deep understanding of healthcare dynamics and early-stage startup challenges to assist its companies in achieving their goals.
What is the typical check size for investments?
Nina Capital's check sizes range from €200,000 to €1,500,000, providing flexibility to support various stages of company development.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.